Glenmark drug for treating uncontrolled asthma gets Indian regulator’s nod

Glenmark drug for treating uncontrolled asthma gets Indian regulator’s nod

Mumbai-based Glenmark has got the Indian regulator’s approval for a drug to treat patients of uncontrolled asthma. The fixed dose combination (FDC) drug will be sold under the brand name Indamet. An FDC drug combines two or more active ingredients into a single pill in a fixed dosage ratio. Indamet–a combination of Indacaterol and Mometasone–will …

Glenmark drug for treating uncontrolled asthma gets Indian regulator’s nod Read More »